Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
International Journal of Oncology|November 3, 2010
Molecular cloning and characterization of a novel esophageal cancer related geneYongping Cui, Meixia Bi, Tao Su, et al.Methods in Enzymology|November 14, 2007
Hypoxia and the unfolded protein responseConstantinos Koumenis, Meixia Bi, Jiangbin Ye, et al.Biochemical and Biophysical Research Communications|March 21, 2003
ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosisYongping Cui, Jianbo Wang, Xinyu Zhang, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|February 7, 2004
Gastrin regulates the heparin-binding epidermal-like growth factor promoter via a PKC/EGFR-dependent mechanismNatalie F Sinclair, Wandong Ai, Raktima Raychowdhury, et al.Molecular and Cellular Biology|August 18, 2004
Activating transcription factor 4 is translationally regulated by hypoxic stressJaime D Blais, Vasilisa Filipenko, Meixia Bi, et al.The EMBO Journal|September 9, 2005
ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growthMeixia Bi, Christine Naczki, Marianne Koritzinsky, et al.Molecular Imaging and Biology|October 20, 2022
Immuno-PET Monitoring of CD8+ T Cell Infiltration Post ICOS Agonist Antibody Treatment Alone and in Combination with PD-1 Blocking Antibody Using a 89Zr Anti-CD8+ Mouse Minibody in EMT6 Syngeneic Tumor MouseHasan Alsaid, Shih-Hsun Cheng, Meixia Bi, et al.The Journal of Clinical Investigation|November 13, 2012
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growthLori S Hart, John T Cunningham, Tatini Datta, et al.Plos One|November 3, 2018
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironmentsJong W Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra, et al.Cancer Research Communications|August 18, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint BlockadeSapna Yadavilli, Jeremy D Waight, Sara Brett, et al.Pageof 1